Your browser doesn't support javascript.
loading
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
Hamaguchi, Tetsuya; Denda, Tadamichi; Kudo, Toshihiro; Sugimoto, Naotoshi; Ura, Takashi; Yamazaki, Kentaro; Fujii, Hirofumi; Kajiwara, Takeshi; Nakajima, Takako Eguchi; Takahashi, Shin; Otsu, Satoshi; Komatsu, Yoshito; Nagashima, Fumio; Moriwaki, Toshikazu; Esaki, Taito; Sato, Takeo; Itabashi, Michio; Oki, Eiji; Sasaki, Toru; Chiron, Marielle; Yoshino, Takayuki.
Afiliação
  • Hamaguchi T; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Denda T; Department of Gastroenterology, Chiba Cancer Center, Chiba, Japan.
  • Kudo T; Osaka University Graduate School of Medicine, Suita, Japan.
  • Sugimoto N; Department of Medical Oncology, Osaka Medical Center for Cancer and Cardiovascular Disease, Osaka, Japan.
  • Ura T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yamazaki K; Department of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Fujii H; Department of Clinical Oncology, Jichi Medical University Hospital, Shimotsuke, Japan.
  • Kajiwara T; Department of Gastrointestinal Medical Oncology, Shikoku Cancer Center, Matsuyama, Japan.
  • Nakajima TE; Department of Medical Oncology, St. Marianna University School of Medicine Hospital, Kawasaki, Japan.
  • Takahashi S; Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan.
  • Otsu S; Department of Medical Oncology, Oita University Hospital, Yufu, Japan.
  • Komatsu Y; Department of Cancer Center, Hokkaido University Hospital, Sapporo, Japan.
  • Nagashima F; Department of Medical Oncology, Kyorin University Hospital, Mitaka, Japan.
  • Moriwaki T; Department of Gastroenterology, University of Tsukuba Hospital, Tsukuba, Japan.
  • Esaki T; Department of Gastrointestinal and Medical Oncology, National Kyushu Cancer Center, Fukuoka, Japan.
  • Sato T; Department of Gastrointestinal Surgery, Kitasato University East Hospital, Sagamihara, Japan.
  • Itabashi M; Department of Surgery 2, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Oki E; Department of Gastrointestinal Surgery, Kyushu University Hospital, Fukuoka, Japan.
  • Sasaki T; Research and development, Sanofi K. K., Tokyo, Japan.
  • Chiron M; Biomarkers & Imaging Genomics, Sanofi, Alfortville, France.
  • Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Cancer Sci ; 110(11): 3565-3572, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31520559
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Proteínas Recombinantes de Fusão / Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Neoplasias do Colo / Receptores de Fatores de Crescimento do Endotélio Vascular Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Proteínas Recombinantes de Fusão / Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Neoplasias do Colo / Receptores de Fatores de Crescimento do Endotélio Vascular Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article